Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 7Other hematologic neoplasm 6Genitourinary 5CNS 5Thoracic 4Tumor-Agnostic 3Sarcoma 2Plasma cell 2Head & Neck 2Breast 2

Conditions

Radiation Injuries 1Neoplasms 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 631Radiotherapy 339pembrolizumab 329Cetuximab 284Docetaxel 226Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 77toripalimab 75Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 50Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 44130-nm albumin-bound paclitaxel 44tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adrenal Cortex Hormones × Head & Neck × Clear all
NCT02410382 2019-05-14

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

University of Arizona

Phase 2 Terminated
79 enrolled
Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasms

NCT01621880 2019-01-09

BRAIN

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Completed
112 enrolled 10 charts
Head & Neck

Nasopharyngeal Carcinoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡